Appendix 4E & Annual Report
Filed with ASX · · 83 pages · English
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- Market Update COVID-19
- December 2019 Quarterly Update
- ACW 2019 AGM Chairman's Address
- R&D Tax Incentive rebate received of $4.58 million
- September 2019 Quarterly Update
Later from Actinogen Medical
- ACW announces two clinical trials & launches capital raising
- Proposed issue of Securities - ACW
- Actinogen Presentation & Planned Conference Call
- Offer Booklet
- R&D Tax Incentive Rebate received of A$2.9 million
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical